Open Access
Open access
volume 8 issue 3 pages 3895-3932

Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis

Publication typeJournal Article
Publication date2016-12-11
scimago Q2
SJR0.785
CiteScore5.6
Impact factor
ISSN19492553
Oncology
Abstract
Virally induced liver cancer usually evolves over long periods of time in the context of a strongly oxidative microenvironment, characterized by chronic liver inflammation and regeneration processes. They ultimately lead to oncogenic mutations in many cellular signaling cascades that drive cell growth and proliferation. Oxidative stress, induced by hepatitis viruses, therefore is one of the factors that drives the neoplastic transformation process in the liver. This review summarizes current knowledge on oxidative stress and oxidative stress responses induced by human hepatitis B and C viruses. It focuses on the molecular mechanisms by which these viruses activate cellular enzymes/systems that generate or scavenge reactive oxygen species (ROS) and control cellular redox homeostasis. The impact of an altered cellular redox homeostasis on the initiation and establishment of chronic viral infection, as well as on the course and outcome of liver fibrosis and hepatocarcinogenesis will be discussed The review neither discusses reactive nitrogen species, although their metabolism is interferes with that of ROS, nor antioxidants as potential therapeutic remedies against viral infections, both subjects meriting an independent review.
Found 
Found 

Top-30

Journals

2
4
6
8
10
International Journal of Molecular Sciences
10 publications, 6.58%
Antioxidants
7 publications, 4.61%
Viruses
6 publications, 3.95%
Cells
5 publications, 3.29%
Oxidative Medicine and Cellular Longevity
5 publications, 3.29%
Molecular Biology
3 publications, 1.97%
Molecules
3 publications, 1.97%
Cancers
3 publications, 1.97%
Infectious Disorders - Drug Targets
2 publications, 1.32%
World Journal of Gastrointestinal Oncology
2 publications, 1.32%
World Journal of Gastroenterology
2 publications, 1.32%
World Journal of Clinical Cases
2 publications, 1.32%
Frontiers in Pharmacology
2 publications, 1.32%
Frontiers in Immunology
2 publications, 1.32%
Scientific Reports
2 publications, 1.32%
Free Radical Biology and Medicine
2 publications, 1.32%
Molecular Aspects of Medicine
2 publications, 1.32%
Reviews in Medical Virology
2 publications, 1.32%
Hepatology
2 publications, 1.32%
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
1 publication, 0.66%
Antioxidants and Redox Signaling
1 publication, 0.66%
Oncology Reports
1 publication, 0.66%
Anti-Cancer Drugs
1 publication, 0.66%
Chinese Medical Journal
1 publication, 0.66%
International Journal of Biological Markers
1 publication, 0.66%
Biomedicines
1 publication, 0.66%
International Journal of Environmental Research and Public Health
1 publication, 0.66%
Microorganisms
1 publication, 0.66%
Frontiers in Endocrinology
1 publication, 0.66%
2
4
6
8
10

Publishers

5
10
15
20
25
30
35
40
MDPI
40 publications, 26.32%
Elsevier
24 publications, 15.79%
Springer Nature
17 publications, 11.18%
Wiley
12 publications, 7.89%
Frontiers Media S.A.
8 publications, 5.26%
Hindawi Limited
7 publications, 4.61%
Baishideng Publishing Group
7 publications, 4.61%
Taylor & Francis
6 publications, 3.95%
Bentham Science Publishers Ltd.
4 publications, 2.63%
Pleiades Publishing
3 publications, 1.97%
Spandidos Publications
2 publications, 1.32%
Ovid Technologies (Wolters Kluwer Health)
2 publications, 1.32%
SAGE
2 publications, 1.32%
Science Alert
2 publications, 1.32%
Cold Spring Harbor Laboratory
2 publications, 1.32%
Paediatrician Publishers LLC
1 publication, 0.66%
Mary Ann Liebert
1 publication, 0.66%
Maad Rayan Publishing Company
1 publication, 0.66%
Neoplasia Press
1 publication, 0.66%
IntechOpen
1 publication, 0.66%
IGI Global
1 publication, 0.66%
Georg Thieme Verlag KG
1 publication, 0.66%
American Society for Microbiology
1 publication, 0.66%
American Chemical Society (ACS)
1 publication, 0.66%
Microbiology Society
1 publication, 0.66%
National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications)
1 publication, 0.66%
AME Publishing Company
1 publication, 0.66%
5
10
15
20
25
30
35
40
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
152
Share
Cite this
GOST |
Cite this
GOST Copy
Tyurina D. A. et al. Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis // Oncotarget. 2016. Vol. 8. No. 3. pp. 3895-3932.
GOST all authors (up to 50) Copy
Иванов А. В., Tyurina D. A., Bartosch B., Kushch A. A., Ivanova O., Кочетков С. Н., Isaguliants M. G. Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis // Oncotarget. 2016. Vol. 8. No. 3. pp. 3895-3932.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.18632/oncotarget.13904
UR - https://doi.org/10.18632/oncotarget.13904
TI - Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis
T2 - Oncotarget
AU - Иванов, А. В.
AU - Tyurina, Daria A.
AU - Bartosch, Birke
AU - Kushch, A. A.
AU - Ivanova, Olga
AU - Кочетков, С. Н.
AU - Isaguliants, Maria G.
PY - 2016
DA - 2016/12/11
PB - Impact Journals
SP - 3895-3932
IS - 3
VL - 8
PMID - 27965466
SN - 1949-2553
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2016_Tyurina,
author = {А. В. Иванов and Daria A. Tyurina and Birke Bartosch and A. A. Kushch and Olga Ivanova and С. Н. Кочетков and Maria G. Isaguliants},
title = {Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis},
journal = {Oncotarget},
year = {2016},
volume = {8},
publisher = {Impact Journals},
month = {dec},
url = {https://doi.org/10.18632/oncotarget.13904},
number = {3},
pages = {3895--3932},
doi = {10.18632/oncotarget.13904}
}
MLA
Cite this
MLA Copy
Tyurina, Daria A., et al. “Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis.” Oncotarget, vol. 8, no. 3, Dec. 2016, pp. 3895-3932. https://doi.org/10.18632/oncotarget.13904.